Engineering of core promoter regions enables the construction of constitutive and inducible promoters in Halomonas sp.

Development of an enhanced chromosomal expression system based on porin synthesis operon for halophile Halomonas sp.

(2014) Jin Yin et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Development of Halomonas TD01 as a host for open production of chemicals

(2014) Xiao-Zhi Fu et al.   METABOLIC ENGINEERING

A Synthetic Anhydrotetracycline-Controllable Gene Expression System in Ralstonia eutropha H16

(2014) Han Li et al.   ACS Synthetic Biology

Design, construction and characterisation of a synthetic promoter library for fine-tuned gene expression in actinomycetes

(2013) Theresa Siegl et al.   METABOLIC ENGINEERING

Metabolic Engineering: Past and Future

(2013) Benjamin M. Woolston et al.   Annual Review of Chemical and Biomolecular Engineering

Promoter engineering: Recent advances in controlling transcription at the most fundamental level

(2012) John Blazeck et al.   Biotechnology Journal

Overview of Regulatory Strategies and Molecular Elements in Metabolic Engineering of Bacteria

(2012) Tianwen Wang et al.   MOLECULAR BIOTECHNOLOGY

Unsterile and continuous production of polyhydroxybutyrate by Halomonas TD01

(2011) Dan Tan et al.   BIORESOURCE TECHNOLOGY

Metabolic Engineering of Bacteria

(2011) Ravi R. Kumar et al.   INDIAN JOURNAL OF MICROBIOLOGY

Development of an anhydrotetracycline-inducible gene expression system for solvent-producing Clostridium acetobutylicum: A useful tool for strain engineering

(2011) Hongjun Dong et al.   METABOLIC ENGINEERING

Comparative genomics study of polyhydroxyalkanoates (PHA) and ectoine relevant genes from Halomonas sp. TD01 revealed extensive horizontal gene transfer events and co-evolutionary relationships

(2011) Lei Cai et al.   Microbial Cell Factories

Regulation of Alternative Sigma Factor Use

(2010) Sofia Österberg et al.   Annual Review of Microbiology

Recombinant Expression in Moderate Halophiles

(2010) Masao Tokunaga et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Golden Gate Shuffling: A One-Pot DNA Shuffling Method Based on Type IIs Restriction Enzymes

(2009) Carola Engler et al.   PLoS One